CervoMed CRVO
NASDAQ CRVO
$2.62 +0.06 (+2.34%)
At close: Aug 21, 2026 · 4:00 PM EDT

CervoMed (CRVO) Revenue (2011 - 2025)

CervoMed (CRVO) posted Revenue of $8726.0 for Q4 2025, down 97.29% sequentially from $322569.0 in Q3 2025, and down 99.6% YoY from $2.2 million in Q4 2024.

CervoMed (CRVO) Revenue (2011 - 2025) Analysis & Trends

CervoMed has reported Revenue for 6 years, with the latest figure at $8726.0 in Q4 2025.

  • Quarterly Revenue fell 99.6% year-over-year to $8726.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 77.56% YoY) and the FY2025 annual result came in at $4.0 million, down 58.86% from the prior year.
  • Revenue retreated to $8726.0 in Q4 2025 per CRVO's latest filing, from $322569.0 in the prior quarter.
  • Over five years, Revenue peaked at $3.3 million in Q2 2024 and troughed at $8726.0 in Q4 2025.
  • A 3-year average of $1.7 million and a median of $1.8 million in 2025 frame the typical range for Revenue.
  • The sharpest annual moves came in 2024 and 2025: Revenue jumped 91.23% in 2024, then sank 99.6% in 2025.
  • Over 3 years, Revenue stood at $2.5 million in 2023, then declined by 13.19% to $2.2 million in 2024, then tumbled by 99.6% to $8726.0 in 2025.
  • According to Business Quant data, Revenue over the past three periods registered $8726.0, $322569.0, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.29 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1.06 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 425.49 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 674.14 Mn
10 CervoMed 26.64 Mn 26.64 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 8,726.00
Sep 30, 2025 322,569.00
Jun 30, 2025 1.76 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 2.16 Mn
Sep 30, 2024 1.94 Mn
Jun 30, 2024 3.29 Mn
Mar 31, 2024 2.35 Mn
Dec 31, 2023 2.49 Mn
Sep 30, 2023 1.53 Mn
Jun 30, 2023 1.72 Mn
Mar 31, 2023 1.41 Mn
Jun 30, 2013 71,667.00
Sep 30, 2012 143,334.00
Jun 30, 2012 143,334.00
Mar 31, 2012 159,542.00
Dec 31, 2011 320,275.00
Sep 30, 2011 250,201.00